Polypill in cardiovascular disease prevention: recent advances

Keyphrases

• Recent Advances 100%
• Cardiovascular Prevention 100%
• Polypill 100%
• Cardiovascular Mortality 50%
• Secondary Prevention 50%
• Single pill 50%
• Risk Factors 25%
• Cardiovascular Risk 25%
• Antihypertensive Drugs 25%
• Myocardial Infarction 25%
• Drug Combination 25%
• Prevention Strategies 25%
• Comorbidity 25%
• Pharmacologic 25%
• Recurring 25%
• Therapeutic Strategies 25%
• Treatment Regimen 25%
• Triple Therapy 25%
• Randomized Clinical Trial 25%
• Total Mortality 25%
• Optimal Treatment 25%
• Cardiovascular Events 25%
• Usual Care 25%
• Primary Prevention 25%
• Non-fatal 25%
• Low Adherence 25%
• Secondary Prevention of Cardiovascular Diseases 25%
• Risk Factor Control 25%
• Multiple Risk Factors 25%
• Antiplatelet Agents 25%
• Effective Implementation 25%
• Review Update 25%
• Cardiovascular Drugs 25%
• Treatment Risk 25%
• Rent 25%
• Primary Barrier 25%
• Treatment Simplification 25%
• Personal Effectiveness 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Cardiovascular Disease 100%
• Antihypertensive Agent 50%
• Prevalence 50%
• Heart Infarction 50%
• Cardiovascular Risk 50%
• Clinical Study 50%
• Randomized Clinical Trial 50%
• Cardiovascular Mortality 50%
• Antithrombocytic Agent 50%
• Cardiovascular Agent 50%
• Comorbidity 50%

Medicine and Dentistry

• Cardiovascular System 100%
• Cardiovascular Disease Prevention 100%
• Polypill 100%
• Secondary Prevention 50%
• Antihypertensive Agent 16%
• Prevalence 16%
• Cardiovascular Disease 16%
• Myocardial Infarction 16%
• Randomized Clinical Trial 16%
• Cardiovascular Risk 16%
• Clinical Study 16%
• Antiplatelet Drug 16%
• Primary Prevention 16%
• Cardiovascular Mortality 16%
• Cardiovascular Agent 16%
• Comorbidity 16%